Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases

Anticancer Research

Volumn 31, Issue 4, 2011, Pages 1215-1224

  Bandapalli, Obul Reddy ^a   Hariri, Nawid ^a   Macher Göppinger, Stephan ^a   Kahlert, Christoph ^a   Schirmacher, Peter ^a   Brand, Karsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Apoptosis; Colorectal cancer; FAS; Invasion front; Liver metastases; TRAIL

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; DEATH RECEPTOR 5; FAS LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; LIVER CELL; LIVER METASTASIS; MACROPHAGE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; STELLATE CELL; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79956074993     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Becker N and Wahrendorf J: Krebsatlas der Bundesrepublik Deutschland. Springer, Berlin, 1997.
2. Dreben JA and Niederhuber JE: Cancer of the lower gastrointestinal tract. In: Current Therapy in Oncology. Niederhuber JE (ed.). Decker, St. Louis, MO, USA, pp. 426-431, 1993.
3. Grem JL: Current treatment approaches in colorectal cancer. Semin Oncol 18: 17-26, 1991.
4. Curley SA, Izzo F, Abdalla E and Vauthey JN: Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 23: 165-182, 2004.
5. Arnold D and Seufferlein T: Targeted treatments in colorectal cancer: state of the art and future perspectives. Gut 59: 838-858, 2010.
6. Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, Iwakura Y, Yagita H and Okumura K: Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7: 94-100, 2001 (Pubitemid 32095647)
7. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM and Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
8. O'Connell J, Bennett MW, Nally K, Houston A, O'Sullivan GC and Shanahan F: Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. Ann NY Acad Sci 910: 178-192; discussion 193-175, 2000.
9. Yoong KF, Afford SC, Randhawa S, Hubscher SG and Adams DH: FAS/FAS ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol 154: 693-703, 1999. (Pubitemid 29122588)
10. Bandapalli OR, Dihlmann S, Helwa R, Macher-Goeppinger S, Weitz J, Schirmacher P and Brand K: Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases. J Pathol 218: 370-379, 2009.
11. Bandapalli OR, Geheeb M, Kobelt D, Kuehnle K, Elezkurtaj S, Herrmann J, Gressner AM, Weiskirchen R, Beule D, Bluthgen N, Herzel H, Franke C and Brand K: Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 118: 74-89, 2006. (Pubitemid 41681582)
12. Bandapalli OR, Kahlert C, Hellstern V, Galindo L, Schirmacher P, Weitz J and Brand K: Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens. BMC Genomics 9: 448, 2008.
13. Kahlert C, Bandapalli OR, Schirmacher P, Weitz J and Brand K: Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res 28: 1459-1465, 2008. (Pubitemid 351892917)
14. Brand K, Baker AH, Perez-Canto A, Possling A, Sacharjat M, Geheeb M and Arnold W: Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 60: 5723-5730, 2000.
15. Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR and Erlander MG: Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 5: 117-122, 1999. (Pubitemid 29051009)
16. Luzzi V, Holtschlag V and Watson MA: Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol 158: 2005-2010, 2001.
17. Bluthgen N, Brand K, Cajavec B, Swat M, Herzel H and Beule D: Biological profiling of gene groups utilizing gene ontology. Genome Inform 16: 106-115, 2005.
18. Timmers M, Vekemans K, Vermijlen D, Asosingh K, Kuppen P, Bouwens L, Wisse E and Braet F: Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 112: 793-802, 2004. (Pubitemid 39435264)
19. Vekemans K, Braet F, Muyllaert D and Wisse E: Nitric oxide from rat liver sinusoidal endothelial cells induces apoptosis in IFN gamma-sensitized CC531s colon carcinoma cells. J Hepatol 41: 11-18, 2004. (Pubitemid 39005146)
20. Braet F, Nagatsuma K, Saito M, Soon L, Wisse E and Matsuura T: The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol 13: 821-825, 2007. (Pubitemid 46470289)
21. Vekemans K, Braet F and Wisse E: DiO-labeled CC531s colon carcinoma cells traverse the hepatic sinusoidal endothelium via the Fas/FasL pathway. J Gastrointest Surg 8: 371-372; author reply 372, 2004.
22. Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, Goovaerts G, Dirix LY and Van Marck E: Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 195: 336-342, 2001.
23. Paku S, Kopper L and Nagy P: Development of the vasculature in 'pushing-type' liver metastases of an experimental colorectal cancer. Int J Cancer 115: 893-902, 2005.
24. Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004. (Pubitemid 39551661)
25. De Wever O and Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 200: 429-447, 2003. (Pubitemid 36818244)
26. Mueller MM and Fusenig NE: Friends or foes - bipolar effects of the umour stroma in cancer. Nat Rev Cancer 4: 839-849, 2004. (Pubitemid 39472951)
27. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
28. Matsusue R, Kubo H, Hisamori S, Okoshi K, Takagi H, Hida K, Nakano K, Itami A, Kawada K, Nagayama S and Sakai Y: Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 16: 2645-2653, 2009.
29. Paschos KA, Majeed AW and Bird NC: Role of Kupffer cells in the outgrowth of colorectal cancer liver metastases. Hepatol Res 40: 83-94, 2010.
30. Mahalingam D, Szegezdi E, Keane M, Jong S and Samali A: TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev 35: 280-288, 2009.
31. Falschlehner C, Ganten TM, Koschny R, Schaefer U and Walczak H: TRAIL and other TRAIL receptor agonists as novel cancer therapeutics. Adv Exp Med Biol 647: 195-206, 2009.
32. Kruyt FA: TRAIL and cancer therapy. Cancer Lett 263: 14-25, 2008.
33. Giovarelli M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T and Forni G: A 'stealth effect': adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T-cell reactions. J Immunol 163: 4886-4893, 1999. (Pubitemid 29501253)
34. + immune cells in clinical colorectal cancer. Eur J Canc 46: 2314-2323, 2010.
35. Coney LR, Daniel PT, Sanborn D, Dhein J, Debatin KM, Krammer PH and Zurawski VR Jr.: Apoptotic cell death induced by a mouse-human anti-APO-1 chimeric antibody leads to tumor regression. Int J Cancer 58: 562-567, 1994. (Pubitemid 24268100)
36. Lucking-Famira KM, Daniel PT, Moller P, Krammer PH and Debatin KM: APO-1 (CD95)-mediated apoptosis in human T-ALL engrafted in SCID mice, Leukemia 8: 1825-1833, 1994.
37. O'Connell J, O'Sullivan GC, Collins JK and Shanahan F: The Fas counterattack: Fas-mediated T-cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184: 1075-1082, 1996.
38. O'Connell J, Bennett MW, O'Sullivan GC, Roche D, Kelly J, Collins JK and Shanahan F: FAS ligand expression in primary colon adenocarcinomas: evidence that the FAS counterattack is a prevalent mechanism of immune evasion in human colon cancer. J Pathol 186: 240-246, 1998. (Pubitemid 28494350)
39. Igney FH and Krammer PH: Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol 71: 907-920, 2002.